Home › Companies › RAPT THERAPEUTICS INC. › 2024-2025
At RAPT THERAPEUTICS INC.'s shareholder meeting held May 29, 2025, in the 2024-2025 proxy season, 99 asset managers reported how they voted in their SEC Form N-PX filings, covering 905 separate fund positions. Their filings are grouped here into 8 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. RAPT THERAPEUTICS INC.'s own Form 8-K tally for this meeting is published below, but no row in it could be matched to the most widely held item, so this page states no certified outcome for that item. On that item — To indicate, on an advisory basis, the preferred frequency of stockholder advisory votes on the… — the reporting funds and managers cast 99.7% of the shares they voted in favour (FOR divided by FOR plus AGAINST plus WITHHELD; abstained and unvoted shares are excluded because neither took a side). Fund and manager reports are combined in it and may count the same shares twice: it adds fund reports to institutional-manager reports, which can cover the same shares. It is not the company's certified result.
Download data (CSV): ballot items · votes by manager · column guide.
Compiled from SEC Form N-PX filings and RAPT THERAPEUTICS INC.’s Form 8-K, filed May 29, 2025 (Item 5.07 on EDGAR). Page generated November 8, 2026.
Meeting of May 29, 2025: 6 items on RAPT THERAPEUTICS INC.’s Form 8-K, filed May 29, 2025: 2 approved · 4 without a stated outcome.
Material dissent: a director nominee under 80% of the votes cast, say-on-pay under 70%, any other item the board put forward under 80%, or a shareholder proposal with more than 50%, on the company’s own Form 8-K tally. How this is decided
Proxy season: 2024-2025
Explore RAPT THERAPEUTICS INC. in the interactive database Compare manager voting policies
These tallies are RAPT THERAPEUTICS INC.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed May 29, 2025 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Support (of votes cast) | Reported outcome | Voting standard |
|---|---|---|---|---|---|---|---|---|
| Elect Director: Dr. Michael F. Giordano | 76,980,669 | -- | -- | 23,581,705 | 16,091,881 | 77% | Not verified | — |
| Elect Director: Ernst & Young LLP | 116,338,761 | 129,183 | 186,311 | -- | -- | 99.8% | Not verified | — |
| 3. Non-Binding Advisory Vote on the Compensation of the Company's Named Executive Officers | 76,867,722 | 23,639,125 | 55,527 | -- | 16,091,881 | 76% | Not verified | — |
| 5. Approval of the Amendment of the Company's Amended and Restated Certificate of Incorporation to Effect, at the Discretion of the Board of Directors, a Reverse Stock Split of the Company's Issued and Outstanding Common Stock, at a Ratio of One-for-Eight (the | 115,742,755 | 905,360 | 6,140 | -- | -- | 99.2% | Approved | — |
| 6. Approval of the 2025 Plan | 76,671,022 | 23,835,621 | 55,731 | -- | 16,091,881 | 76% | Not verified | — |
| Approval of the Amendment and Restatement of the ESPP | 100,236,929 | 322,582 | 2,863 | -- | 16,091,881 | 99.6% | Approved | — |
Source: RAPT THERAPEUTICS INC., Form 8-K, filed with the SEC on May 29, 2025 — read the filing on EDGAR.
Each item below shows how the 99 asset managers that disclosed a RAPT THERAPEUTICS INC. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of RAPT THERAPEUTICS INC.’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.
Combines 2 wordings of this item as funds reported it.
77% Majority: yes · of votes cast
Description as filed by funds: To elect one Class III director to hold office until RAPT Therapeutics, Inc.'s 2028 annual meeting of stockholders or until his successor has been duly elected and qualified: Dr. Michael F. Giordano
RAPT THERAPEUTICS INC.’s own tally for this item (“Elect Director: Dr. Michael F. Giordano”): 76,980,669 for, 23,581,705 withheld, per its Form 8-K filed May 29, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 77% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 33 asset managers below reported 28,386 for, 9,545,216 withheld.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 0 | 0 | 0 | 6,864,436 | Withhold |
| Fidelity | 0 | 0 | 0 | 1,099,441 | Withhold |
| BlackRock | 0 | 0 | 0 | 430,877 | Withhold |
| SEI | 0 | 0 | 0 | 184,711 | Withhold |
| Goldman Sachs | 0 | 0 | 0 | 166,627 | Withhold |
| Federated Hermes | 0 | 0 | 0 | 159,126 | Withhold |
| Charles Schwab | 0 | 0 | 0 | 150,946 | Withhold |
| BRIDGEWAY FUNDS INC | 0 | 0 | 0 | 125,000 | Withhold |
| ETF Series Solutions | 0 | 0 | 0 | 113,738 | Withhold |
| Equitable | 0 | 0 | 0 | 65,336 | Withhold |
| Invesco | 0 | 0 | 0 | 43,507 | Withhold |
| Lincoln Financial | 21,400 | 0 | 0 | 3,300 | Mixed |
| Nationwide | 0 | 0 | 0 | 20,801 | Withhold |
| Global X | 0 | 0 | 0 | 17,853 | Withhold |
| Pacific Life | 0 | 0 | 0 | 17,519 | Withhold |
| AIG/SunAmerica | 0 | 0 | 0 | 14,697 | Withhold |
| Northern Trust | 0 | 0 | 0 | 13,570 | Withhold |
| Bridge Builder Trust | 0 | 0 | 0 | 13,445 | Withhold |
| Jackson National | 0 | 0 | 0 | 8,416 | Withhold |
| ProShares | 0 | 0 | 0 | 6,921 | Withhold |
| Blackstone Alternative Investment Funds | 0 | 0 | 0 | 6,800 | Withhold |
| WILSHIRE MUTUAL FUNDS INC | 0 | 0 | 0 | 4,984 | Withhold |
| DWS | 0 | 0 | 0 | 4,548 | Withhold |
| TIAA | 3,771 | 0 | 0 | 0 | For |
| Calvert | 0 | 0 | 0 | 2,913 | Withhold |
Showing the 25 largest of 33 asset managers. All 33 are in the interactive database (link above).
Combines 2 wordings of this item as funds reported it.
99.2% Approved · of votes cast
Description as filed by funds: TO APPROVE THE AMENDMENT OF RAPT THERAPEUTICS, INC.'S AMENDED AND RESTATED CERTIFICATE OF INCORPORATION TO EFFECT, AT THE DISCRETION OF THE BOARD OF DIRECTORS, A REVERSE STOCK SPLIT OF RAPT THERAPEUTICS INC.'S ISSUED AND OUTSTANDING COMMON STOCK, AT A RATIO OF ONE-FOR-EIGHT.
RAPT THERAPEUTICS INC.’s own tally for this item (“5. Approval of the Amendment of the Company's Amended and Restated Certificate of Incorporation to Effect, at the Discretion of the Board of Directors, a Reverse Stock Split of the Company's Issued and Outstanding Common”): 115,742,755 for, 905,360 against — passed, per its Form 8-K filed May 29, 2025 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “The Company's stockholders approved the Reverse Stock Split Proposal.”
Support: 99.2% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 33 asset managers below reported 9,414,476 for, 159,126 against.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 6,864,436 | 0 | 0 | 0 | For |
| Fidelity | 1,099,441 | 0 | 0 | 0 | For |
| BlackRock | 430,877 | 0 | 0 | 0 | For |
| SEI | 184,711 | 0 | 0 | 0 | For |
| Goldman Sachs | 166,627 | 0 | 0 | 0 | For |
| Federated Hermes | 0 | 159,126 | 0 | 0 | Against |
| Charles Schwab | 150,946 | 0 | 0 | 0 | For |
| BRIDGEWAY FUNDS INC | 125,000 | 0 | 0 | 0 | For |
| ETF Series Solutions | 113,738 | 0 | 0 | 0 | For |
| Equitable | 65,336 | 0 | 0 | 0 | For |
| Invesco | 43,507 | 0 | 0 | 0 | For |
| Lincoln Financial | 24,700 | 0 | 0 | 0 | For |
| Nationwide | 20,801 | 0 | 0 | 0 | For |
| Global X | 17,853 | 0 | 0 | 0 | For |
| Pacific Life | 17,519 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 14,697 | 0 | 0 | 0 | For |
| Northern Trust | 13,570 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 13,445 | 0 | 0 | 0 | For |
| Jackson National | 8,416 | 0 | 0 | 0 | For |
| ProShares | 6,921 | 0 | 0 | 0 | For |
| Blackstone Alternative Investment Funds | 6,800 | 0 | 0 | 0 | For |
| WILSHIRE MUTUAL FUNDS INC | 4,984 | 0 | 0 | 0 | For |
| DWS | 4,548 | 0 | 0 | 0 | For |
| TIAA | 3,771 | 0 | 0 | 0 | For |
| Calvert | 2,913 | 0 | 0 | 0 | For |
Showing the 25 largest of 33 asset managers. All 33 are in the interactive database (link above).
76% Majority: yes · of votes cast
Description as filed by funds: TO APPROVE RAPT THERAPEUTICS, INC.'S 2025 EQUITY INCENTIVE PLAN.
RAPT THERAPEUTICS INC.’s own tally for this item (“6. Approval of the 2025 Plan”): 76,671,022 for, 23,835,621 against, per its Form 8-K filed May 29, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 76% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 33 asset managers below reported 9,573,602 against.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 0 | 6,864,436 | 0 | 0 | Against |
| Fidelity | 0 | 1,099,441 | 0 | 0 | Against |
| BlackRock | 0 | 430,877 | 0 | 0 | Against |
| SEI | 0 | 184,711 | 0 | 0 | Against |
| Goldman Sachs | 0 | 166,627 | 0 | 0 | Against |
| Federated Hermes | 0 | 159,126 | 0 | 0 | Against |
| Charles Schwab | 0 | 150,946 | 0 | 0 | Against |
| BRIDGEWAY FUNDS INC | 0 | 125,000 | 0 | 0 | Against |
| ETF Series Solutions | 0 | 113,738 | 0 | 0 | Against |
| Equitable | 0 | 65,336 | 0 | 0 | Against |
| Invesco | 0 | 43,507 | 0 | 0 | Against |
| Lincoln Financial | 0 | 24,700 | 0 | 0 | Against |
| Nationwide | 0 | 20,801 | 0 | 0 | Against |
| Global X | 0 | 17,853 | 0 | 0 | Against |
| Pacific Life | 0 | 17,519 | 0 | 0 | Against |
| AIG/SunAmerica | 0 | 14,697 | 0 | 0 | Against |
| Northern Trust | 0 | 13,570 | 0 | 0 | Against |
| Bridge Builder Trust | 0 | 13,445 | 0 | 0 | Against |
| Jackson National | 0 | 8,416 | 0 | 0 | Against |
| ProShares | 0 | 6,921 | 0 | 0 | Against |
| Blackstone Alternative Investment Funds | 0 | 6,800 | 0 | 0 | Against |
| WILSHIRE MUTUAL FUNDS INC | 0 | 4,984 | 0 | 0 | Against |
| DWS | 0 | 4,548 | 0 | 0 | Against |
| TIAA | 0 | 3,771 | 0 | 0 | Against |
| Calvert | 0 | 2,913 | 0 | 0 | Against |
Showing the 25 largest of 33 asset managers. All 33 are in the interactive database (link above).
99.6% Approved · of votes cast
Description as filed by funds: TO APPROVE THE AMENDMENT AND RESTATEMENT OF RAPT THERAPEUTICS, INC.'S 2019 EMPLOYEE STOCK PURCHASE PLAN TO REMOVE THE EVERGREEN PROVISION AND INCREASE THE AGGREGATE NUMBER OF SHARES OF THE RAPT THERAPEUTICS, INC.'S COMMON STOCK RESERVED FOR ISSUANCE UNDER THE ESPP BY 4,000,000 SHARES.
RAPT THERAPEUTICS INC.’s own tally for this item (“Approval of the Amendment and Restatement of the ESPP”): 100,236,929 for, 322,582 against — passed, per its Form 8-K filed May 29, 2025 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “The Company's stockholders approved the 2025 Plan.”
Support: 99.6% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 33 asset managers below reported 9,573,602 for.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 6,864,436 | 0 | 0 | 0 | For |
| Fidelity | 1,099,441 | 0 | 0 | 0 | For |
| BlackRock | 430,877 | 0 | 0 | 0 | For |
| SEI | 184,711 | 0 | 0 | 0 | For |
| Goldman Sachs | 166,627 | 0 | 0 | 0 | For |
| Federated Hermes | 159,126 | 0 | 0 | 0 | For |
| Charles Schwab | 150,946 | 0 | 0 | 0 | For |
| BRIDGEWAY FUNDS INC | 125,000 | 0 | 0 | 0 | For |
| ETF Series Solutions | 113,738 | 0 | 0 | 0 | For |
| Equitable | 65,336 | 0 | 0 | 0 | For |
| Invesco | 43,507 | 0 | 0 | 0 | For |
| Lincoln Financial | 24,700 | 0 | 0 | 0 | For |
| Nationwide | 20,801 | 0 | 0 | 0 | For |
| Global X | 17,853 | 0 | 0 | 0 | For |
| Pacific Life | 17,519 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 14,697 | 0 | 0 | 0 | For |
| Northern Trust | 13,570 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 13,445 | 0 | 0 | 0 | For |
| Jackson National | 8,416 | 0 | 0 | 0 | For |
| ProShares | 6,921 | 0 | 0 | 0 | For |
| Blackstone Alternative Investment Funds | 6,800 | 0 | 0 | 0 | For |
| WILSHIRE MUTUAL FUNDS INC | 4,984 | 0 | 0 | 0 | For |
| DWS | 4,548 | 0 | 0 | 0 | For |
| TIAA | 3,771 | 0 | 0 | 0 | For |
| Calvert | 2,913 | 0 | 0 | 0 | For |
Showing the 25 largest of 33 asset managers. All 33 are in the interactive database (link above).
Combines 4 wordings of this item as funds reported it.
99.7% Fund and manager reports combined; may count the same shares twice · no official result
Description as filed by funds: To indicate, on an advisory basis, the preferred frequency of stockholder advisory votes on the compensation of RAPT Therapeutics, Inc.'s named executive officers.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice). The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 0 | 0 | 0 | 0 | -- |
| Fidelity | 0 | 0 | 0 | 0 | -- |
| BlackRock | 0 | 0 | 0 | 0 | -- |
| SEI | 0 | 0 | 0 | 0 | -- |
| Goldman Sachs | 0 | 0 | 0 | 0 | -- |
| Federated Hermes | 0 | 0 | 0 | 0 | -- |
| Charles Schwab | 0 | 0 | 0 | 0 | -- |
| BRIDGEWAY FUNDS INC | 0 | 0 | 0 | 0 | -- |
| ETF Series Solutions | 0 | 0 | 0 | 0 | -- |
| Equitable | 0 | 0 | 0 | 0 | -- |
| Invesco | 0 | 0 | 0 | 0 | -- |
| Lincoln Financial | 0 | 0 | 0 | 0 | -- |
| Nationwide | 0 | 0 | 0 | 0 | -- |
| Global X | 0 | 0 | 0 | 0 | -- |
| Pacific Life | 0 | 0 | 0 | 0 | -- |
| AIG/SunAmerica | 0 | 0 | 0 | 0 | -- |
| Northern Trust | 0 | 0 | 0 | 0 | -- |
| Bridge Builder Trust | 0 | 0 | 0 | 0 | -- |
| Jackson National | 0 | 0 | 0 | 0 | -- |
| ProShares | 0 | 0 | 0 | 0 | -- |
| Blackstone Alternative Investment Funds | 0 | 0 | 0 | 0 | -- |
| WILSHIRE MUTUAL FUNDS INC | 0 | 0 | 0 | 0 | -- |
| DWS | 0 | 0 | 0 | 0 | -- |
| TIAA | 0 | 0 | 0 | 0 | -- |
| Calvert | 0 | 0 | 0 | 0 | -- |
Fund voting reports, all 33 managers: 9,559,734 1 year, 13,868 3 year. Showing the 25 largest; every one is in the interactive database (link above).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Medicxi Ventures Management (Jersey) Ltd | 0 | 0 | 0 | 0 | -- |
| ORBIMED ADVISORS LLC | 0 | 0 | 0 | 0 | -- |
| Redmile Group, LLC | 0 | 0 | 0 | 0 | -- |
| Deep Track Capital, LP | 0 | 0 | 0 | 0 | -- |
| ADAR1 Capital Management, LLC | 0 | 0 | 0 | 0 | -- |
| PERCEPTIVE ADVISORS LLC | 3,352,807 | 0 | 0 | 0 | For |
| GEODE CAPITAL MANAGEMENT, LLC | 0 | 0 | 0 | 0 | -- |
| BlackRock | 0 | 0 | 0 | 0 | -- |
| State Street | 0 | 0 | 0 | 0 | -- |
| SEI | 0 | 0 | 0 | 0 | -- |
| Northern Trust | 0 | 0 | 0 | 0 | -- |
| Federated Hermes | 0 | 0 | 0 | 0 | -- |
| Charles Schwab | 0 | 0 | 0 | 0 | -- |
| Two Sigma | 0 | 0 | 0 | 0 | -- |
| MELLON INVESTMENTS Corp | 0 | 0 | 0 | 0 | -- |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 0 | 0 | 0 | 0 | -- |
| Renaissance | 0 | 0 | 0 | 0 | -- |
| Vanguard | 0 | 0 | 0 | 0 | -- |
| DE Shaw | 0 | 0 | 0 | 0 | -- |
| AQR | 0 | 0 | 0 | 0 | -- |
| Invesco | 0 | 0 | 0 | 0 | -- |
| Citadel | 0 | 0 | 0 | 0 | -- |
| AllianceBernstein | 0 | 0 | 0 | 0 | -- |
| Nuveen | 0 | 0 | 0 | 0 | -- |
| Goldman Sachs | 0 | 0 | 0 | 0 | -- |
Institutional-manager reports, all 69 managers: 3,352,807 for, 9,776 against, 50,625,641 1 year, 49,035 3 year. Showing the 25 largest; every one is in the interactive database (link above).
Combines 2 wordings of this item as funds reported it.
76% Majority: yes · of votes cast
Description as filed by funds: To approve, on an advisory basis, the compensation of RAPT Therapeutics, Inc.'s name executive officers.
RAPT THERAPEUTICS INC.’s own tally for this item (“3. Non-Binding Advisory Vote on the Compensation of the Company's Named Executive Officers”): 76,867,722 for, 23,639,125 against, per its Form 8-K filed May 29, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 76% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
Also reported under other wordings, matched to the same row of RAPT THERAPEUTICS INC.’s official tally and shown with their own fund figures; their managers are not in the figures or the table on this card: “To approve, on an advisory basis, the compensation of the Company's named executive officers” (6 managers, 14,464,463 for, 14,187 against).
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 0 | 6,864,436 | 0 | 0 | Against |
| Fidelity | 0 | 1,099,441 | 0 | 0 | Against |
| Goldman Sachs | 0 | 166,627 | 0 | 0 | Against |
| BRIDGEWAY FUNDS INC | 0 | 125,000 | 0 | 0 | Against |
| Equitable | 0 | 65,336 | 0 | 0 | Against |
| Invesco | 0 | 43,507 | 0 | 0 | Against |
| Lincoln Financial | 21,400 | 3,300 | 0 | 0 | Mixed |
| Nationwide | 0 | 20,801 | 0 | 0 | Against |
| Pacific Life | 0 | 17,519 | 0 | 0 | Against |
| AIG/SunAmerica | 0 | 14,697 | 0 | 0 | Against |
| Northern Trust | 0 | 13,570 | 0 | 0 | Against |
| ProShares | 0 | 6,921 | 0 | 0 | Against |
| Blackstone Alternative Investment Funds | 0 | 6,800 | 0 | 0 | Against |
| DWS | 0 | 4,548 | 0 | 0 | Against |
| TIAA | 0 | 3,771 | 0 | 0 | Against |
| Calvert | 0 | 2,913 | 0 | 0 | Against |
| Dimensional | 0 | 2,152 | 0 | 0 | Against |
| T. Rowe Price | 0 | 1,901 | 0 | 0 | Against |
| State Street | 1,675 | 0 | 0 | 0 | For |
| PENN SERIES FUNDS INC | 1,000 | 0 | 0 | 0 | For |
| Brinker Capital Destinations Trust | 540 | 0 | 0 | 0 | For |
| Guggenheim | 0 | 274 | 0 | 0 | Against |
Fund voting reports, all 22 managers: 24,615 for, 8,463,514 against.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| ADAR1 Capital Management, LLC | 0 | 5,026,936 | 0 | 0 | Against |
| GEODE CAPITAL MANAGEMENT, LLC | 0 | 1,265,988 | 0 | 0 | Against |
| State Street | 404,416 | 2,729 | 0 | 0 | For |
| Two Sigma | 0 | 139,370 | 0 | 0 | Against |
| MELLON INVESTMENTS Corp | 0 | 132,415 | 0 | 0 | Against |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 0 | 125,000 | 0 | 0 | Against |
| Renaissance | 0 | 87,530 | 0 | 0 | Against |
| Vanguard | 0 | 80,326 | 0 | 0 | Against |
| DE Shaw | 0 | 64,636 | 0 | 0 | Against |
| AQR | 0 | 61,757 | 0 | 0 | Against |
| Invesco | 0 | 53,458 | 0 | 0 | Against |
| Citadel | 50,949 | 0 | 0 | 0 | For |
| AllianceBernstein | 0 | 50,710 | 0 | 0 | Against |
| Nuveen | 0 | 43,989 | 0 | 0 | Against |
| Goldman Sachs | 0 | 38,910 | 0 | 0 | Against |
| Fidelity | 0 | 31,823 | 0 | 0 | Against |
| Dimensional | 0 | 24,843 | 0 | 0 | Against |
| Rhumbline | 0 | 9,776 | 0 | 0 | Against |
| PARAMETRIC PORTFOLIO ASSOCIATES LLC | 0 | 15,246 | 0 | 0 | Against |
| REGENTS OF THE UNIVERSITY OF CALIFORNIA | 0 | 9,673 | 0 | 0 | Against |
| T. Rowe Price | 0 | 8,961 | 0 | 0 | Against |
| Ethic Inc. | 0 | 8,598 | 0 | 0 | Against |
| Calvert | 0 | 2,913 | 0 | 0 | Against |
| Legal & General Investment Management America Inc | 0 | 2,379 | 0 | 0 | Against |
| PUBLIC EMPLOYEES RETIREMENT SYSTEM OF OHIO | 0 | 1,964 | 0 | 0 | Against |
Institutional-manager reports, all 38 managers: 455,365 for, 7,297,679 against, 9,776 1 year. Showing the 25 largest; every one is in the interactive database (link above).
Combines 3 wordings of this item as funds reported it.
76% Majority: yes · of votes cast
Description as filed by funds: To approve, on an advisory basis, the compensation of RAPT Therapeutics, Inc.'s named executive officers.
RAPT THERAPEUTICS INC.’s own tally for this item (“3. Non-Binding Advisory Vote on the Compensation of the Company's Named Executive Officers”): 76,867,722 for, 23,639,125 against, per its Form 8-K filed May 29, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 76% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| BlackRock | 0 | 430,877 | 0 | 0 | Against |
| SEI | 0 | 184,711 | 0 | 0 | Against |
| Federated Hermes | 0 | 159,126 | 0 | 0 | Against |
| Charles Schwab | 0 | 150,946 | 0 | 0 | Against |
| ETF Series Solutions | 0 | 113,738 | 0 | 0 | Against |
| Global X | 0 | 17,853 | 0 | 0 | Against |
| Bridge Builder Trust | 0 | 13,445 | 0 | 0 | Against |
| Jackson National | 0 | 8,416 | 0 | 0 | Against |
| WILSHIRE MUTUAL FUNDS INC | 0 | 4,984 | 0 | 0 | Against |
| Innovator ETFs Trust | 0 | 884 | 0 | 0 | Against |
| Advisors' Inner Circle Fund III | 0 | 493 | 0 | 0 | Against |
Fund voting reports, all 11 managers: 1,085,473 against.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Medicxi Ventures Management (Jersey) Ltd | 22,352,000 | 0 | 0 | 0 | For |
| ORBIMED ADVISORS LLC | 6,567,630 | 0 | 0 | 0 | For |
| Redmile Group, LLC | 0 | 6,345,891 | 0 | 0 | Against |
| Deep Track Capital, LP | 6,011,380 | 0 | 0 | 0 | For |
| Nantahala Capital Management, LLC | 4,970,975 | 0 | 0 | 0 | For |
| PERCEPTIVE ADVISORS LLC | 3,352,807 | 0 | 0 | 0 | For |
| BlackRock | 22,052 | 869,161 | 0 | 0 | Against |
| SEI | 0 | 184,711 | 0 | 0 | Against |
| Northern Trust | 0 | 177,852 | 0 | 0 | Against |
| Federated Hermes | 0 | 167,123 | 0 | 0 | Against |
| Charles Schwab | 0 | 150,946 | 0 | 0 | Against |
| OSBORNE PARTNERS CAPITAL MANAGEMENT, LLC | 24,000 | 0 | 0 | 0 | For |
| WASHINGTON STATE INVESTMENT BOARD | 0 | 13,110 | 0 | 0 | Against |
| NEW YORK STATE COMMON RETIREMENT FUND | 0 | 11,549 | 0 | 0 | Against |
| STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM | 0 | 9,095 | 0 | 0 | Against |
| LOS ANGELES CAPITAL MANAGEMENT LLC | 0 | 5,971 | 0 | 0 | Against |
| Callan Family Office, LLC | 4,822 | 0 | 0 | 0 | For |
| BANK OF AMERICA NA | 0 | 4,780 | 0 | 0 | Against |
| PNC BANK, NATIONAL ASSOCIATION | 0 | 3,813 | 0 | 0 | Against |
| Prudential/PGIM | 0 | 2,045 | 0 | 0 | Against |
| MACKENZIE FINANCIAL CORP | 0 | 1,691 | 0 | 0 | Against |
| Russell Investments | 0 | 1,600 | 0 | 0 | Against |
| NISA INVESTMENT ADVISORS, LLC | 0 | 1,432 | 0 | 0 | Against |
| MML INVESTORS SERVICES, LLC | 789 | 0 | 0 | 0 | For |
| L2 Asset Management, LLC | 0 | 493 | 0 | 0 | Against |
Institutional-manager reports, all 33 managers: 43,306,681 for, 7,951,843 against. Showing the 25 largest; every one is in the interactive database (link above).
99.8% Majority: yes · of votes cast
Description as filed by funds: RATIFICATION OF THE APPOINTMENT OF ERNST & YOUNG LLP AS THE INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM OF RAPT THERAPEUTICS, INC. FOR ITS FISCAL YEAR ENDING DECEMBER 31, 2025.
RAPT THERAPEUTICS INC.’s own tally for this item (“Elect Director: Ernst & Young LLP”): 116,338,761 for, 129,183 against, per its Form 8-K filed May 29, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 99.8% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 33 asset managers below reported 9,573,602 for.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 6,864,436 | 0 | 0 | 0 | For |
| Fidelity | 1,099,441 | 0 | 0 | 0 | For |
| BlackRock | 430,877 | 0 | 0 | 0 | For |
| SEI | 184,711 | 0 | 0 | 0 | For |
| Goldman Sachs | 166,627 | 0 | 0 | 0 | For |
| Federated Hermes | 159,126 | 0 | 0 | 0 | For |
| Charles Schwab | 150,946 | 0 | 0 | 0 | For |
| BRIDGEWAY FUNDS INC | 125,000 | 0 | 0 | 0 | For |
| ETF Series Solutions | 113,738 | 0 | 0 | 0 | For |
| Equitable | 65,336 | 0 | 0 | 0 | For |
| Invesco | 43,507 | 0 | 0 | 0 | For |
| Lincoln Financial | 24,700 | 0 | 0 | 0 | For |
| Nationwide | 20,801 | 0 | 0 | 0 | For |
| Global X | 17,853 | 0 | 0 | 0 | For |
| Pacific Life | 17,519 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 14,697 | 0 | 0 | 0 | For |
| Northern Trust | 13,570 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 13,445 | 0 | 0 | 0 | For |
| Jackson National | 8,416 | 0 | 0 | 0 | For |
| ProShares | 6,921 | 0 | 0 | 0 | For |
| Blackstone Alternative Investment Funds | 6,800 | 0 | 0 | 0 | For |
| WILSHIRE MUTUAL FUNDS INC | 4,984 | 0 | 0 | 0 | For |
| DWS | 4,548 | 0 | 0 | 0 | For |
| TIAA | 3,771 | 0 | 0 | 0 | For |
| Calvert | 2,913 | 0 | 0 | 0 | For |
Showing the 25 largest of 33 asset managers. All 33 are in the interactive database (link above).
Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 132,288,686 shares outstanding at the time of that meeting.
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Vanguard | 5.19% |
| 2 | Fidelity | 0.83% |
| 3 | BlackRock | 0.33% |
| 4 | SEI | 0.14% |
| 5 | Goldman Sachs | 0.13% |
| 6 | Federated Hermes | 0.12% |
| 7 | Charles Schwab | 0.11% |
| 8 | BRIDGEWAY FUNDS INC | 0.09% |
| 9 | ETF Series Solutions | 0.09% |
| 10 | Equitable | 0.05% |
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Medicxi Ventures Management (Jersey) Ltd | 16.90% |
| 2 | ORBIMED ADVISORS LLC | 4.96% |
| 3 | Redmile Group, LLC | 4.80% |
| 4 | Deep Track Capital, LP | 4.54% |
| 5 | ADAR1 Capital Management, LLC | 3.80% |
| 6 | PERCEPTIVE ADVISORS LLC | 2.53% |
| 7 | GEODE CAPITAL MANAGEMENT, LLC | 0.96% |
| 8 | BlackRock | 0.67% |
| 9 | State Street | 0.31% |
| 10 | SEI | 0.14% |
As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row names its form.
| Holder | % outstanding | Disclosure |
|---|---|---|
| Perceptive Advisors LLC | 4.44% | 13G |
| BlackRock, Inc. | 1.74% | 13G |
| ForGrowth III PA B.V. | 1.39% | 13G |
| Redmile Group, LLC | 1.33% | 13G |
| Glazer Capital, LLC | 1.12% | 13G |
| The Vanguard Group | 0.53% | 13G |
| Nantahala Capital Management, LLC | 0.47% | 13G |
| Deep Track Capital, LP | 0.08% | 13G |
Percentages above are of 132,288,686 shares outstanding, as reported by RAPT THERAPEUTICS INC. on its Form 10-Q dated May 2, 2025 (see the filing on EDGAR). This is the count contemporaneous with the 2024-2025 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.
Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from RAPT THERAPEUTICS INC.’s 10-Q dated May 2, 2025. This page is a static snapshot rebuilt weekly on November 8, 2026; a live search always shows the current data.
RAPT THERAPEUTICS INC. proxy season coverage: 2024-2025 (this page).
proxyvotesnow.com, “RAPT THERAPEUTICS INC. 2025 Annual Meeting: Shareholder Vote Results”, https://proxyvotesnow.com/company/rapt-therapeutics-inc/2025 (version of November 9, 2026). Derived from SEC Form N-PX and Form 8-K filings; tables licensed CC BY 4.0. Licence: CC BY 4.0.